Clinical trial
Evaluation of the Pathobiology of CALR-mutated MPN Cells
NCT06480591 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Pathobiology of CALR-mutated MPN Cells
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 21, 2025
- Completion date
- September 30, 2027
- Enrollment
- 35 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
myeloproliferative neoplasm